Zosano Pharma Corp (ZSAN): M James Barrett , 10% owner of Zosano Pharma Corp sold 23,681 shares on Jul 19, 2016. The Insider selling transaction was reported by the company on Jul 21, 2016 to the Securities and Exchange Commission. The shares were sold at $1.25 per share for a total value of $30,132.20 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Jul 15, 2016, M James Barrett (10% owner) sold 13,382 shares at $1.20 per share price.
Zosano Pharma Corp: On Wednesday, Jul 20, 2016 heightened volatility was witnessed in Zosano Pharma Corp which led to swings in the share price. The shares opened for trading at $1.1224 and hit $1.47 on the upside , eventually ending the session at $1.3, with a gain of 17.12% or 0.19 points. The heightened volatility saw the trading volume jump to 1,40,854 shares. The 52-week high of the share price is $9.243 and the company has a market cap of $16 M . The 52-week low of the share price is at $1.03.
Zosano Pharma Corporation is a clinical-stage specialty pharmaceutical company. The company has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a range of indications. Its microneedle patch system offers rapid onset consistent drug delivery and improved ease of use and room-temperature stability. Its microneedle patch system has the potential to deliver numerous medications for a range of indications in commercially attractive markets. The Company’s short-wear-time transdermal patch consists of an array of titanium microneedles that is coated with its formulation of an existing drug and attached to an adhesive patch. Its lead product candidates and the indications they are expected to treat include Daily ZP-PTH for severe osteoporosis; ZP-Glucagon for severe hypoglycemia and ZP-Triptan for migraine.